Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Ascendis Pharma A/S (ASND) had Debt to Capital Ratio of 1.73 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$279.27M |
|
$-42.91M |
|
$27.10M |
|
$252.17M |
|
$276.41M |
|
$2.87M |
|
$-38.09M |
|
$-35.22M |
|
$-35.22M |
|
$-42.91M |
|
$-42.91M |
|
$-42.91M |
|
$-42.91M |
|
$2.87M |
|
$7.84M |
|
60.61M |
|
60.61M |
|
$-0.69 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$1.25B |
|
$165.73M |
|
$219.02M |
|
$1.47B |
|
$1.21B |
|
$435.88M |
|
$448.03M |
|
$1.66B |
|
$-184.22M |
|
$-188.41M |
|
$-184.22M |
|
61.98M |
|
| Cash Flow Statement Financials | |
$60.98M |
|
$-9.60M |
|
$41.10M |
|
$633.07M |
|
$696.99M |
|
$63.92M |
|
$131.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
1.73 |
-5.35 |
|
90.29% |
|
1.03% |
|
1.03% |
|
-- |
|
-12.61% |
|
-15.37% |
|
$51.38M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.08 |
|
1.57 |
|
57.50 |
|
23.29% |
|
22.77% |
|
-2.91% |
|
-17.05% |
|
$-2.97 |
|
$0.85 |
|
$1.01 |
|